Company intelligence / Profile preview

Bodhi Research & Development

Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Bodhi Research & Development is a Canadian cannabis-focused research company founded by neurosurgeon Dr. Neilank K. Jha that has conducted clinical trials to evaluate cannabinoids for managing concussion symptoms and developed a patent-pending nutraceutical product for concussion, but no late-stage clinical or approved products are reported yet.[4][6]

Therapeutic areas: Neurology
Modalities: Small moleculeCannabinoid-based therapyNutraceutical
Industry: Biotech

Partnerships

Green Relief

Beyond the preview

Go deeper on Bodhi Research & Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bodhi Research & Development.

Explore the full profile